Mark For: EVEREST™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88584518 |
Mark Literal Elements | EVEREST |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | GENERIC WEB UPDATE 2020-11-30 |
Basis | 1(b) |
Class Status | ABANDONED |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | No |
Intent To Use | Yes |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | David Devernoe |
Attorney Docket Number | 5557.27003 |
Law Office Assigned | L50 |
Employee Name | FIORELLI, JOANNA ELISA |
2017-10-27 | Date of First Use |
2019-08-19 | Application Filed |
2019-11-20 | Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED |
2019-11-20 | Status: Live/Pending |
2019-11-25 | Transaction Date |
2020-09-22 | Published |
2020-11-30 | Location: GENERIC WEB UPDATE |
2020-11-30 | Status: Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Tra |
Party: | EverNov Medicines Limited |
Address | 66th Floor, Tower 1, Plaza 66 West Nanjing 1266 Shanghai CHINA 200040 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | CHINA |
Drawing | JPEG | 2019-08-19 |
Specimen | JPEG | 2019-08-19 |
TEAS RF New Application | MULTI | 2019-08-19 |
Administrative Response | XML | 2019-10-16 |
XSearch Search Summary | XML | 2019-11-18 |
Offc Action Outgoing | MULTI | 2019-11-20 |
Response to Office Action | MULTI | 2020-04-15 |
Specimen | JPEG | 2020-04-15 |
Amendment and Mail Process Complete | MULTI | 2020-04-17 |
Offc Action Outgoing | XML | 2020-06-04 |
Response to Office Action | MULTI | 2020-06-24 |
Amendment and Mail Process Complete | MULTI | 2020-07-14 |
Offc Action Outgoing | XML | 2020-08-03 |
Response to Office Action | XML | 2020-08-17 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-08-18 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-08-19 |
Notice of Publication | XML | 2020-09-02 |
Notification Of Notice of Publication | XML | 2020-09-02 |
OG Publication Confirmation | APPLICATION/XML | 2020-09-22 |
Express Abandonment | XML | 2020-11-24 |
Notice of Abandonment | APPLICATION/XML | 2020-11-30 |
IC 001. US 001 005 006 010 026 046. G & S: Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals; pharmaceutical research; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical services; research and development of pharmaceuticals; pharmaceutical preparations for health care; medicated and pharmaceutical preparations for use in connection with humans. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027
IC 042. US 100 101. G & S: Drug Development; drug discovery; pharmaceutical drug development services; research and development of vaccines and medicines. FIRST USE: 20171027. FIRST USE IN COMMERCE: 20171027
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2020-11-30 | |
ABANDONMENT - AFTER PUBLICATION | 2020-11-30 | |
TEAS EXPRESS ABANDONMENT RECEIVED | 2020-11-24 | |
PUBLISHED FOR OPPOSITION | 2020-09-22 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-09-22 | |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2020-09-22 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-09-02 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-08-18 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-17 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-08-17 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-17 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-08-03 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-08-03 | 93657 |
NON-FINAL ACTION E-MAILED | 2020-08-03 | 6325 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-07-13 | 66213 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-07-13 | 66213 |
ASSIGNED TO LIE | 2020-07-06 | 66213 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-06-24 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-04 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-06-04 | 93657 |
NON-FINAL ACTION E-MAILED | 2020-06-04 | 6325 |
ASSIGNED TO EXAMINER | 2020-05-20 | 93657 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-16 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-15 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-15 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-20 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-11-20 | 90289 |
NON-FINAL ACTION E-MAILED | 2019-11-20 | 6325 |
ASSIGNED TO EXAMINER | 2019-11-18 | 90289 |
LETTER OF PROTEST EVIDENCE FORWARDED | 2019-10-16 | |
LETTER OF PROTEST ACCEPTED | 2019-10-16 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-09-04 | |
NEW APPLICATION ENTERED IN TRAM | 2019-08-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.